Company page

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. is a public biotechnology company traded under the ticker CAPR on the American stock market. The company focuses on developing innovative therapies for cardiovascular diseases and other serious conditions. With a market capitalization of approximately $1.14 billion, Capricor is positioned in the healthcare sector, aiming to advance its clinical programs and bring new treatments to patients.